Orgentec specializes in diagnostic assays that are used by laboratories in more than 100 countries. The company develops and produces tests, primarily enzyme-linked immunosorbent assays (ELISA), that help diagnose the increasing number of people impacted by autoimmune disorders and infectious diseases. It is one of the only companies in its field to offer a proprietary automated instrument – the Alegria – and associated test kits that enable labs to complete multiple assays and deliver faster results than traditional tests. Headquartered in Germany, Orgentec has a strong position in Europe and a growing presence in Asia, Latin America and the Middle East. Water Street invested in Orgentec in 2014 and helped the company acquire Corgenix in 2015 to establish a strong foothold in the United States. We are continuing to work with the leadership team to expand Orgentec into new areas of testing and geographic markets.
CEO & PresidentWork with us
Jim Widergren is CEO and president of Orgentec and Corgenix, global diagnostics specialty testing companies. He is a former senior vice president of global customer operations at Beckman Coulter, where he was responsible for all sales, service and customer support operations worldwide. Previously, Jim was group vice president for the chemistry and automation systems business group, corporate vice president for Asia Pacific and Latin America commercial operations, and vice president and treasurer of Beckman Coulter. Prior to joining Beckman Coulter, he held financial management positions with Ferguson Partners, a commercial real estate development firm and Malcolm Lewis Associates, a consulting firm, and was an applications engineer with Allied Signal Corp. In addition, he conducted research on economic development in Asia as a Fellow of the Thomas J. Watson Foundation. A registered professional mechanical engineer (PE) in California, Jim holds a bachelor of science degree in engineering and a master of engineering degree from Harvey Mudd College, a master of business administration degree from the University of California at Los Angeles, and completed the Stanford Executive Program at Stanford University. Jim is the vice-chairman of the Board of Trustees of the Keck Graduate Institute of Applied Life Sciences.